• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Measuring financial risk protection in health benefits packages: scoping review protocol to inform allocative efficiency studies.测量健康福利计划中的财务风险保护:为分配效率研究提供信息的范围综述方案。
BMJ Open. 2019 May 28;9(5):e026554. doi: 10.1136/bmjopen-2018-026554.
2
Protocol for a scoping review of implementation research approaches to universal health coverage in Africa.非洲全民健康覆盖实施研究方法的范围审查方案
BMJ Open. 2021 Feb 15;11(2):e041721. doi: 10.1136/bmjopen-2020-041721.
3
Digital technologies for health financing in low-income and middle-income countries: a scoping review protocol.数字技术在中低收入国家卫生筹资中的应用:系统评价方案
BMJ Open. 2024 Jun 4;14(6):e080132. doi: 10.1136/bmjopen-2023-080132.
4
Ethics of Procuring and Using Organs or Tissue from Infants and Newborns for Transplantation, Research, or Commercial Purposes: Protocol for a Bioethics Scoping Review.从婴儿和新生儿获取器官或组织用于移植、研究或商业目的的伦理问题:生物伦理学范围审查方案
Wellcome Open Res. 2024 Dec 5;9:717. doi: 10.12688/wellcomeopenres.23235.1. eCollection 2024.
5
Identifying priorities for research on financial risk protection to achieve universal health coverage: a scoping overview of reviews.识别金融风险保护研究优先事项以实现全民健康覆盖:综述的范围概述。
BMJ Open. 2022 Mar 9;12(3):e052041. doi: 10.1136/bmjopen-2021-052041.
6
Multimorbidity in children and youth: a scoping review protocol.儿童和青少年的多种疾病:范围综述方案。
BMJ Open. 2018 May 24;8(5):e022413. doi: 10.1136/bmjopen-2018-022413.
7
Conceptualising, operationalising and measuring trust in participatory health research networks: a scoping review protocol.概念化、操作化和衡量参与式健康研究网络中的信任:范围综述方案。
BMJ Open. 2020 Oct 29;10(10):e038840. doi: 10.1136/bmjopen-2020-038840.
8
Quality indicators for substance use disorder care: a scoping review protocol.物质使用障碍护理的质量指标:一项范围综述方案
BMJ Open. 2025 Mar 29;15(3):e085216. doi: 10.1136/bmjopen-2024-085216.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
Financial risk protection and universal health coverage: evidence and measurement challenges.金融风险保护与全民健康覆盖:证据与衡量挑战
PLoS Med. 2014 Sep 22;11(9):e1001701. doi: 10.1371/journal.pmed.1001701. eCollection 2014 Sep.

引用本文的文献

1
Catastrophic health expenditure associated with non-inpatient costs among middle-aged and older individuals in China.中国中老年人群中与非住院费用相关的灾难性卫生支出
Front Public Health. 2025 Jan 17;12:1454531. doi: 10.3389/fpubh.2024.1454531. eCollection 2024.
2
Technical efficiency of national HIV/AIDS spending in 78 countries between 2010 and 2018: A data envelopment analysis.2010年至2018年78个国家国家艾滋病毒/艾滋病支出的技术效率:数据包络分析
PLOS Glob Public Health. 2022 Aug 1;2(8):e0000463. doi: 10.1371/journal.pgph.0000463. eCollection 2022.
3
Assessing progress in the national health financing system towards universal health coverage in Iran: a mixed-method study protocol.评估伊朗国家卫生融资系统在实现全民健康覆盖方面的进展:一项混合方法研究方案。
Health Res Policy Syst. 2021 Jan 12;19(1):4. doi: 10.1186/s12961-020-00610-z.

本文引用的文献

1
Defining a Health Benefits Package: What Are the Necessary Processes?定义健康福利套餐:必要流程有哪些?
Health Syst Reform. 2016 Jan 2;2(1):39-50. doi: 10.1080/23288604.2016.1124171.
2
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.PRISMA 扩展用于范围审查 (PRISMA-ScR): 清单和解释。
Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4.
3
Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016-40.未来卫生筹资和覆盖范围趋势:188 个国家 2016-40 年未来卫生支出和全民健康覆盖
Lancet. 2018 May 5;391(10132):1783-1798. doi: 10.1016/S0140-6736(18)30697-4. Epub 2018 Apr 17.
4
How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.应当如何分配艾滋病毒防治资源?从 23 个国家应用 Optima HIV 中吸取的经验教训。
J Int AIDS Soc. 2018 Apr;21(4):e25097. doi: 10.1002/jia2.25097.
5
Optima Nutrition: an allocative efficiency tool to reduce childhood stunting by better targeting of nutrition-related interventions.最优营养:一种通过更好地针对营养相关干预措施来减少儿童发育迟缓的配置效率工具。
BMC Public Health. 2018 Mar 20;18(1):384. doi: 10.1186/s12889-018-5294-z.
6
The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.全球 Optima HIV 配置效率模型:将资源用于终结艾滋病的努力。
Lancet HIV. 2018 Apr;5(4):e190-e198. doi: 10.1016/S2352-3018(18)30024-9. Epub 2018 Mar 11.
7
Progress on catastrophic health spending in 133 countries: a retrospective observational study.133 个国家灾难性卫生支出进展情况:回顾性观察研究。
Lancet Glob Health. 2018 Feb;6(2):e169-e179. doi: 10.1016/S2214-109X(17)30429-1. Epub 2017 Dec 13.
8
Is the sustainable development goal target for financial risk protection in health realistic?卫生领域金融风险保护的可持续发展目标是否现实?
BMJ Glob Health. 2017 Sep 28;2(3):e000216. doi: 10.1136/bmjgh-2016-000216. eCollection 2017.
9
Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemics.在预算紧张时做出正确决策:利用最佳扩展途径对集中型和混合型艾滋病毒疫情应对措施进行优先排序。
PLoS One. 2017 Oct 3;12(10):e0185077. doi: 10.1371/journal.pone.0185077. eCollection 2017.
10
Priority Setting for Universal Health Coverage: We Need Evidence-Informed Deliberative Processes, Not Just More Evidence on Cost-Effectiveness.全民健康覆盖的优先事项设定:我们需要基于证据的审议过程,而不仅仅是更多关于成本效益的证据。
Int J Health Policy Manag. 2016 Nov 1;5(11):615-618. doi: 10.15171/ijhpm.2016.83.

测量健康福利计划中的财务风险保护:为分配效率研究提供信息的范围综述方案。

Measuring financial risk protection in health benefits packages: scoping review protocol to inform allocative efficiency studies.

机构信息

Institute for Global Health, University College London, London, UK.

出版信息

BMJ Open. 2019 May 28;9(5):e026554. doi: 10.1136/bmjopen-2018-026554.

DOI:10.1136/bmjopen-2018-026554
PMID:31142525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6549617/
Abstract

INTRODUCTION

To progress towards Universal Health Coverage (UHC), countries will need to define a health benefits package of services free at the point of use. Financial risk protection is a core component of UHC and should therefore be considered a key dimension of health benefits packages. Allocative efficiency modelling tools can support national analytical capacity to inform an evidence-based selection of services, but none are currently able to estimate financial risk protection. A review of existing methods used to measure financial risk protection can facilitate their inclusion in modelling tools so that the latter can become more relevant to national decision making in light of UHC.

METHODS AND ANALYSIS

This protocol proposes to conduct a scoping review of existing methods used to measure financial risk protection and assess their potential to inform the selection of services in a health benefits package. The proposed review will follow the methodological framework developed by Arksey and O'Malley and the subsequent recommendations made by Levac . Several databases will be systematically searched including: (1) PubMed; (2) Scopus; (3) Web of Science and (4) Google Scholar. Grey literature will also be scanned, and the bibliography of all selected studies will be hand searched. Following the selection of studies according to defined inclusion and exclusion criteria, key characteristics will be collected from the studies using a data extraction tool. Key characteristics will include the type of method used, geographical region of focus and application to specific services or packages. The extracted data will then be charted, collated, reported and summarised using descriptive statistics, a thematic analysis and graphical presentations.

ETHICS AND DISSEMINATION

The scoping review proposed in this protocol does not require ethical approval. The final results will be disseminated via publication in a peer-reviewed journal, conference presentations and shared with key stakeholders.

摘要

简介

为了实现全民健康覆盖(UHC),各国将需要确定免费提供的服务的健康福利包。财务风险保护是 UHC 的核心组成部分,因此应被视为健康福利包的关键维度。分配效率建模工具可以支持国家分析能力,为基于证据的服务选择提供信息,但目前没有工具能够估计财务风险保护。对用于衡量财务风险保护的现有方法进行审查,可以促进将其纳入建模工具,以便根据 UHC 使后者更能为国家决策提供参考。

方法和分析

本方案旨在对用于衡量财务风险保护的现有方法进行范围审查,并评估其在健康福利包中选择服务的潜在用途。拟议的审查将遵循 Arksey 和 O'Malley 制定的方法框架,并遵循随后由 Levac 提出的建议。将系统地搜索多个数据库,包括:(1)PubMed;(2)Scopus;(3)Web of Science 和(4)Google Scholar。还将扫描灰色文献,并对手头所有选定研究的参考书目进行搜索。根据既定的纳入和排除标准选择研究后,将使用数据提取工具从研究中收集关键特征。关键特征将包括使用的方法类型、关注的地理区域以及对特定服务或套餐的应用。然后使用描述性统计、主题分析和图形演示,对提取的数据进行图表、整理、报告和总结。

伦理和传播

本方案中提出的范围审查不需要伦理批准。最终结果将通过在同行评议期刊上发表、会议报告和与主要利益相关者分享来传播。